Title : Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.

Pub. Date : 2016 Aug 4

PMID : 27488947






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC. Metformin insulin like growth factor 1 receptor Homo sapiens
2 Metformin could target IGF-1R signaling pathway by attenuating PI3K/AKT and MEK/ERK signaling pathways and down-regulating IGF-1R. Metformin insulin like growth factor 1 receptor Homo sapiens
3 Metformin could target IGF-1R signaling pathway by attenuating PI3K/AKT and MEK/ERK signaling pathways and down-regulating IGF-1R. Metformin insulin like growth factor 1 receptor Homo sapiens
4 Finally, we found that combining metformin with CP could further induce IGF-1R down-regulation and was more effective to target NSCLC cells. Metformin insulin like growth factor 1 receptor Homo sapiens